Dr. Vijay Kalaria, M.D.
What this data tells you about Dr. Kalaria
Dr. Vijay Kalaria is a cardiovascular disease in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kalaria performed 3,099 Medicare services across 2,174 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kalaria received a total of $13,466 from 26 pharmaceutical and/or device companies across 182 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalaria is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 579 | $90 | $231 |
| Electrocardiogram (EKG), 12-lead | 334 | $10 | $42 |
| Regadenoson injection (Lexiscan) for heart stress test | 277 | $41 | $120 |
| Echocardiogram, transthoracic | 177 | $141 | $470 |
| Hospital follow-up visit, high complexity | 165 | $92 | $223 |
| Office visit, established patient (20-29 min) | 151 | $65 | $156 |
| Office visit, established patient, complex (40-54 min) | 131 | $126 | $310 |
| Hospital follow-up visit, moderate complexity | 114 | $61 | $155 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 78 | $50 | $196 |
| Chronic care management services for two or more chronic conditions, additional 30 minutes provided personally by health care professional, per calendar month | 68 | $47 | $120 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 64 | $143 | $232 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 63 | $344 | $1,111 |
| Ultrasonic guidance for blood vessel access | 59 | $11 | $22 |
| Ultrasound of leg arteries or artery grafts | 58 | $176 | $700 |
| Initial hospital admission, high complexity | 57 | $133 | $434 |
| Chronic care management, first 20 min/month | 57 | $49 | $95 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 57 | $65 | $120 |
| Ultrasound of both sides of head and neck blood flow | 53 | $135 | $546 |
| Chronic care management, additional 20 min/month | 48 | $37 | $92 |
| Ultrasound study of arm and leg arteries | 44 | $50 | $245 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $71 | $95 |
| New patient office visit, complex (60-74 min) | 33 | $146 | $442 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 32 | $139 | $575 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 30 | $48 | $120 |
| Cardiac catheterization | 28 | $167 | $600 |
| Office visit, established patient (10-19 min) | 27 | $44 | $94 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $19 | $75 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 23 | $663 | $900 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 22 | $9 | $105 |
| Critical care, first 30-74 min | 22 | $166 | $590 |
| Coronary stent placement | 21 | $394 | $1,280 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $85 | $130 |
| Initial hospital admission, moderate complexity | 20 | $101 | $295 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $118 | $531 |
| Sleep study including heart rate, breathing, and sleep time | 18 | $117 | $903 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 17 | $775 | $1,059 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 15 | $1,061 | $2,490 |
| New patient office visit (45-59 min) | 15 | $105 | $355 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 13 | $208 | $840 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $40 | $525 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $188 | $750 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kalaria is a clinical cardiology specialist, with moderate Medicare volume, and speaking/promotional industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kalaria experienced with office visit, established patient (30-39 min)?
Does Dr. Kalaria receive payments from pharmaceutical companies?
How do Dr. Kalaria's costs compare to other cardiovascular diseases in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology